CVE-2025-61940
CVE.org · Published
- Record status
- Published
- Identifier year (not publication year)
- 2025
- Source publication
- Source updated
- Imported by cveboard
- Source snapshot
- cve_2026-10-24_midnight_baseline ·
CNA source text (English)
Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Scoped product and version facts
Fix information unknown; no fixed version is derived here. Missing information does not prove that no fix exists.
Exploitation unknown; this catalogue does not assess exploitation.
EC2 Software NMIS BioDose
- Vendor
- Mirion Medical
- Product
- EC2 Software NMIS BioDose
- Platforms
- Unknown
- Default status
unaffected
| Version (version) | Status (status) | Version scheme (versionType) | Exclusive end (lessThan) | Inclusive end (lessThanOrEqual) | Status changes (at → status) |
|---|---|---|---|---|---|
| 0 | affected | custom | 23.0 | Unavailable | None listed |
| 23.0 | unaffected | Unavailable | Unavailable | Unavailable | None listed |